|
PUS7L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.843500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.216600E-04 |
| Normal-vs-Stage2 |
3.542600E-01 |
| Normal-vs-Stage3 |
7.009400E-01 |
| Normal-vs-Stage4 |
4.812600E-01 |
| Stage1-vs-Stage2 |
4.056200E-01 |
| Stage1-vs-Stage3 |
7.659800E-02 |
| Stage1-vs-Stage4 |
4.787800E-01 |
| Stage2-vs-Stage3 |
6.055800E-01 |
| Stage2-vs-Stage4 |
9.575200E-01 |
| Stage3-vs-Stage4 |
7.050600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.724200E-03 |
| Normal-vs-AfricanAmerican |
7.219500E-02 |
| Normal-vs-Asian |
6.662200E-01 |
| Caucasian-vs-AfricanAmerican |
7.624600E-01 |
| Caucasian-vs-Asian |
7.351800E-01 |
| AfricanAmerican-vs-Asian |
8.165000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.83979999999595E-05 |
| Normal-vs-Female |
3.054600E-01 |
| Male-vs-Female |
1.222610E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.686300E-02 |
| Normal-vs-Extreme_Weight |
2.01470000005255E-06 |
| Normal-vs-Obese |
2.320000E-01 |
| Normal-vs-Extreme_Obese |
3.418700E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.739220E-01 |
| Normal_Weight-vs-Obese |
4.571000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.407000E-01 |
| Extreme_Weight-vs-Obese |
1.320100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.351000E-01 |
| Obese-vs-Extreme_Obese |
2.226200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.153400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.603160E-01 |
| Normal-vs-Age(61-80Yrs) |
7.210300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.52310000001155E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.394400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.184200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.280500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.297700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.442400E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.797400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.975960E-04 |
| Normal-VS-Type2 PRCC |
2.994200E-02 |
| Normal-VS-KIRP CIMP |
3.723000E-01 |
| Normal-VS-Unclassified PRCC |
7.799000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.020600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.735600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.581800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.830300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.187600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.127800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.757840E-03 |
| Normal-vs-N1 |
3.967200E-01 |
| Normal-vs-N2 |
4.008600E-01 |
| N0-vs-N1 |
5.018000E-03 |
| N0-vs-N2 |
5.780000E-01 |
| N1-vs-N2 |
4.625000E-01 |
|
|
